Echo Street Capital Management LLC Dexcom Inc Transaction History

Echo Street Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $861,288 - $1.38 Million	10,008 New	10,008 $933,000
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $337,272 - $398,629	3,243 Added 114.31%	6,080 $706,000
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $241,088 - $348,014	2,837 New	2,837 $321,000
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $7.48 Million - $14.6 Million	110,070 New	110,070 $8.2 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $14.7 Million - $20.4 Million	-156,499 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $5.86 Million - $7.34 Million	45,111 Added 40.5%	156,499 $84 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $11.9 Million - $15.9 Million	111,388 New	111,388 $60.9 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.